bietaserpine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
derivatives of Rauwolfia alkaloids 3687 53-18-9

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • bietaserpine
  • diethylaminoreserpin
  • N-Diethylaminoethylreserpine
hypotensive agent; structure
  • Molecular weight: 707.87
  • Formula: C39H53N3O9
  • CLOGP: 5.64
  • LIPINSKI: 3
  • HAC: 12
  • HDO: 0
  • TPSA: 110.16
  • ALOGS: -5.02
  • ROTB: 15

Drug dosage:

DoseUnitRoute
15 mg O

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
azlogd74 LogD at pH 7.4 3.293 Moderate 0.66
caco2-efflux Caco-2 efflux ratio (BA/AB) 1.026 Moderate 0.66
caco2-intrinsic-papp Caco-2 intrinsic apparent permeability 23.067 10^-6 cm/s Moderate 0.66
dh-clint Dog hepatocyte intrinsic clearance 33.574 uL/min/10^6 cells Moderate 0.66
dppb Dog plasma protein binding (% unbound) 4.920 % Moderate 0.66
fcs-ppb Fetal calf serum protein binding (% unbound) 15.310 % Moderate 0.66
herg hERG pIC50 5.523 pIC50 Moderate 0.66
hh-clint Human hepatocyte intrinsic clearance 27.479 uL/min/10^6 cells Moderate 0.66
hlm-clint Human liver microsomal intrinsic clearance 147.911 uL/min/mg protein Moderate 0.66
hppb Human plasma protein binding (% unbound) 4.290 % Moderate 0.66
kinase-safety-class ACVR2B,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK4,CDK5,CDK9,EIF2AK3,EPHB4,ERBB2,GRK2,ITK,JAK2,JAK3,MAP3K7,MAPK10,MAPK7,MAPKAPK2,MET,NTRK2,PDK2,PDK4,PDPK1,PIK3CA,PIK3CB,PIM2,PRKDC,SIK2,TEK,TGFBR1,ZAP70 33
kinase-selectivity-class AXL,GRK2,PDK4 3
mdck-mdr1-efflux MDCK-MDR1 efflux ratio 0.938 Moderate 0.66
mh-clint Mouse hepatocyte intrinsic clearance 155.597 Moderate 0.66
mppb Mouse plasma protein binding (% unbound) 4.890 Moderate 0.66
nih-mdck-mdr1-efflux NIH MDCK-MDR1 efflux ratio 4.943 Moderate 0.66
pfas-class PFAS structural alert (1 = True, 0 = False) 0
pppb Pig plasma protein binding (% unbound) 14.520 % Moderate 0.66
rh-clint Rat hepatocyte intrinsic clearance 121.899 uL/min/10^6 cells Moderate 0.66
rh-fuinc Rat hepatocyte fraction unbound in incubation 25.090 % Moderate 0.66
rppb Rat plasma protein binding (% unbound) 4.200 % Moderate 0.66
solubility-dd Solubility at pH 7.4 in DMSO 132.739 uM Moderate 0.66

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC C02AA07 CARDIOVASCULAR SYSTEM
ANTIHYPERTENSIVES
ANTIADRENERGIC AGENTS, CENTRALLY ACTING
Rauwolfia alkaloids
ATC C02AA57 CARDIOVASCULAR SYSTEM
ANTIHYPERTENSIVES
ANTIADRENERGIC AGENTS, CENTRALLY ACTING
Rauwolfia alkaloids
ATC C02LA07 CARDIOVASCULAR SYSTEM
ANTIHYPERTENSIVES
ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION
Rauwolfia alkaloids and diuretics in combination
MeSH PA D000959 Antihypertensive Agents
MeSH PA D002317 Cardiovascular Agents
CHEBI has role CHEBI:35674 antihypertensive agent

Related Drugs by ATC class:

C02AA Rauwolfia alkaloids 4 drugs
deserpidinemethoserpidinerescinnaminereserpine
C02LA Rauwolfia alkaloids and diuretics in combination 5 drugs
deserpidinemethoserpidinerescinnaminereserpinesyrosingopine

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 9.96 Basic
pKa2 7.24 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D07167 KEGG_DRUG
C0053565 UMLSCUI
CHEBI:756175 CHEBI
CHEMBL3989595 ChEMBL_ID
DB13575 DRUGBANK_ID
C004538 MESH_SUPPLEMENTAL_RECORD_UI
1686 INN_ID
0P5B94FVD5 UNII
20054848 PUBCHEM_CID

Pharmaceutical products:

None